AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

C-RAD

Regulatory Filings Oct 31, 2016

3148_rns_2016-10-31_4bb6ffd6-6532-47c2-b7e1-4f00df13a971.pdf

Regulatory Filings

Open in Viewer

Opens in native device viewer

Press release 2016-10-31

C-RAD Web Presentation Interim Report Q3 2016

Presentation of the report for the third quarter of the fiscal year 2016:

Date: Monday, November 14, 2016 / kl. 11:00 Venue: Online Presentation

Topic: C-RAD Interim Report Q3 2016

Procedure:

Please register until November 13, 2016 / kl. 18:00 via email to [email protected]

After your registration, you will receive a confirmation via email.

The login data will be distributed to all participants 15 min prior to the meeting.

A recording of the presentation will be made accessible on the C-RAD website after the presentation.

About C-RAD

C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm.

For more information on C-RAD, please visit www.c-rad.com

For further information:

Tim Thurn, CEO C-RAD AB, Phone +46-18-666930, Email [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.